TC
ORGO icon

Truvestments Capital’s Organogenesis Holdings ORGO Stock Holding History

Truvestments Capital’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.5K Sell
12,152
-1,171
-9% -$2.86K ﹤0.01% 629
2026
Q1 		$31.6K Hold
13,323
– – 0.01% 565
2025
Q4 		$69K Buy
13,323
+8,475
+175% +$41.1K 0.01% 399
2025
Q3 		$20.5K Buy
4,848
+935
+24% +$4.35K ﹤0.01% 597
2025
Q2 		$14.3K Buy
+3,913
New +$14.6K ﹤0.01% 596

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Truvestments Capital's ORGO Position: Q2 2026 in Review

Truvestments Capital reduced its Organogenesis Holdings (ORGO) stake by 8.8% in Q2 2026, selling an estimated $2.86K and leaving 12,152 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #629.

Truvestments Capital first reported a position in ORGO in Q2 2025 and has held it in 5 quarters since. The position peaked at $69K in Q4 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Truvestments Capital held 12,152 shares of Organogenesis Holdings worth $29.5K as of Q2 2026.
  • Truvestments Capital sold 1,171 Organogenesis Holdings shares in Q2 2026, an estimated $2.86K.
  • Organogenesis Holdings made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #629 holding.
  • Truvestments Capital first reported a position in Organogenesis Holdings in Q2 2025 and has held it in 5 quarters since.
  • Truvestments Capital's Organogenesis Holdings position peaked at $69K in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.